The role of serum osteoprotegerin and receptor-activator of nuclear factor-Κb ligand in metabolic bone disease of women after obesity surgery

  1. Inicio
  2. »
  3. Sin categoría
  4. »
  5. The role of serum osteoprotegerin and receptor-activator of nuclear factor-Κb...

J Bone Miner Metab. 2016 Nov;34(6):655-661.Watch Full Movie Online Streaming Online and Download

Metabolic bone disease may appear as a complication of obesity surgery. These data show that the osteoprotegerin and receptor-activator of nuclear factor-κB ligand system is  associated with bone markers and bone mineral density at the lumbar spine after obesity surgery

Autor: Balsa JA, Lafuente C, Gómez-Martín JM, Galindo J, Peromingo R,García-Moreno F, Rodriguez-Velasco G, Martínez-Botas J,Gómez-Coronado D, Escobar-Morreale HF, Botella-Carretero JI

Patrocinadores de la web
Lilly
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen
Meiji Pharma
Faes Farma